Amy Rieborn
Leiden, ZH 2333ZA, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
The Effect of Taking Cabozantinib with a Light Breakfast: A Randomized Crossover Pharmacokinetic Study (SKIPPY 1).
Journal: Clinical pharmacokinetics
Published: August 20, 2025
Model-Informed Dose Optimization of Pazopanib in Real-World Patients with Cancer.
Journal: Clinical pharmacokinetics
Published: March 24, 2025
Exploring the Association Between Intra-Patient Variability in Trough Concentration of Pazopanib and Clinical Outcomes in Renal Cell Carcinoma and Soft Tissue Sarcoma Patients.
Journal: Clinical pharmacology and therapeutics
Published: February 04, 2025
Model-informed development of a cost-saving dosing regimen for enfortumab vedotin.
Journal: Cancer chemotherapy and pharmacology
Published: November 27, 2024
Evaluating the Clinical Impact and Feasibility of Therapeutic Drug Monitoring of Pazopanib in a Real-World Soft-Tissue Sarcoma Cohort.
Journal: Clinical pharmacokinetics
Published: June 24, 2024
Population Pharmacokinetics of Cabozantinib in Metastatic Renal Cell Carcinoma Patients: Towards Drug Expenses Saving Regimens.
Journal: Clinical pharmacokinetics
Published: April 18, 2024
Sunitinib for the treatment of metastatic gastrointestinal stromal tumors: the effect of TDM-guided dose optimization on clinical outcomes.
Journal: ESMO open
Published: February 01, 2024
Survival of BRCA1/BRCA2-associated pT1 breast cancer patients, a cohort study.
Journal: Breast cancer research and treatment
Published: January 17, 2022
Showing 1-8 of 8
Last Updated: 09/26/2026